Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters











Publication year range
1.
J Microbiol Biotechnol ; 34(3): 654-662, 2024 Mar 28.
Article in English | MEDLINE | ID: mdl-38213301

ABSTRACT

To investigate the effect of the predominant fungal species from Korean traditional meju and doenjang on soybean fermentation, the enzymatic activity and amino acid production of twenty-two fungal strains were assessed through solid- and liquid-state soybean fermentation. Enzymatic activity analyses of solid-state fermented soybeans revealed different enzyme activities involving protease, leucine aminopeptidase (LAP), carboxypeptidase (CaP), glutaminase, γ-glutamyl transferase (GGT), and amylase, depending on the fungal species. These enzymatic activities significantly affected the amino acid profile throughout liquid-state fermentation. Strains belonging to Mucoromycota, including Lichtheimia, Mucor, Rhizomucor, and Rhizopus, produced smaller amounts of total amino acids and umami-producing amino acids, such as glutamic acid and aspartic acid, than strains belonging to Aspergillus subgenus circumdati. The genera Penicillium and Scopulariopsis produced large amounts of total amino acids and glutamic acid, suggesting that these genera play an essential role in producing umami and kokumi tastes in fermented soybean products. Strains belonging to Aspergillus subgenus circumdati, including A. oryzae, showed the highest amino acid content, including glutamic acid, suggesting the potential benefits of A. oryzae as a starter for soybean fermentation. This study showed the potential of traditional meju strains as starters for soybean fermentation. However, further analysis of processes such as the production of G-peptide for kokumi taste and volatile compounds for flavor and safety is needed.


Subject(s)
Amino Acids , Soy Foods , Amino Acids/metabolism , Soy Foods/microbiology , Glycine max , Fermentation , Fungi , Aspergillus/metabolism , Glutamic Acid/metabolism , Peptide Hydrolases/metabolism
2.
Can J Neurol Sci ; 47(3): 344-349, 2020 05.
Article in English | MEDLINE | ID: mdl-31685057

ABSTRACT

BACKGROUND: Serotonergic dysfunction may play an important role in motor and nonmotor symptoms of Parkinson's disease (PD). The loudness dependence of auditory evoked potentials (LDAEP) has been used to evaluate serotonergic activity. Therefore, this study aimed to determine central serotonergic activity using LDAEP in de novo PD according to the age at onset and changes in serotonergic activity after dopaminergic treatment. METHODS: A total of 30 patients with unmedicated PD, 16 in the early-onset and 14 in the late-onset groups, were enrolled. All subjects underwent comprehensive neurological examination, laboratory tests, the Unified Parkinson's Disease Rating Scale, and LDAEP. The LDAEP was calculated as the slope of the two N1/P2 peaks measured at the Cz electrode, first at baseline conditions (pretreatment) and a second time after 12 weeks (post-treatment) following dopaminergic medications. RESULTS: The absolute values of pretreatment N1/P2 LDAEP (early-onset: late-onset, 0.99 ± 0.68: 1.62 ± 0.88, p = 0.035) and post-treatment N1 LDAEP (early-onset: late-onset, -0.61 ± 0.61: -1.26 ± 0.91, p = 0.03) were significantly lower in the early-onset group compared with those of the late-onset group. In addition, a higher value of pretreatment N1/P2 LDAEP was significantly correlated with the late-onset group (coefficient = 1.204, p = 0.044). The absolute value of the N1 LDAEP decreased after 12 weeks of taking dopaminergic medication (pretreatment: post-treatment, -1.457 ± 1.078: -0.904 ± 0.812, p = 0.0018). CONCLUSIONS: Based on the results of this study, LDAEP could be a marker for serotonergic neurotransmission in PD. Central serotonergic activity assessed by LDAEP may be more preserved in early-onset PD patients and can be altered with dopaminergic medication.


Subject(s)
Auditory Cortex/physiopathology , Evoked Potentials, Auditory/physiology , Parkinson Disease/physiopathology , Serotonin/metabolism , Acoustic Stimulation , Age of Onset , Aged , Aged, 80 and over , Auditory Cortex/physiology , Dopamine Agents/therapeutic use , Electroencephalography , Female , Humans , Male , Middle Aged , Parkinson Disease/drug therapy , Synaptic Transmission/physiology
3.
J Microbiol ; 55(2): 147-152, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28120195

ABSTRACT

γ-Glutamyltranspeptidase (GGT) catalyzes the cleavage of γ-glutamyl compounds and the transfer of γ-glutamyl moiety to water or to amino acid/peptide acceptors. GGT can be utilized for the generation of γ-glutamyl peptides or glutamic acid, which are used as food taste enhancers. In the present study, Bacillus amyloliquefaciens SMB469 with high GGT activity was isolated from Doenjang, a traditional fermented soy food of Korea. The gene encoding GGT from B. amyloliquefaciens SMB469 (BaGGT469) was cloned from the isolate, and heterologously expressed in E. coli and B. subtilis. For comparison, three additional GGT genes were cloned from B. subtilis 168, B. licheniformis DSM 13, and B. amyloliquefaciens FZB42. The BaGGT469 protein was composed of 591 amino acids. The final protein comprises two separate polypeptide chains of 45.7 and 19.7 kDa, generated via autocatalytic cleavage. The specific activity of BaGGT469 was determined to be 17.8 U/mg with γ-L-glutamyl-p-nitroanilide as the substrate and diglycine as the acceptor. GGTs from B. amyloliquefaciens showed 1.4- and 1.7-fold higher transpeptidase activities than those from B. subtilis and B. licheniformis, respectively. Especially, recombinant B. subtilis expressing BaGGT469 demonstrated 11- and 23-fold higher GGT activity than recombinant E. coli and the native B. amyloliquefaciens, respectively, did. These results suggest that BaGGT469 can be utilized for the enzymatic production of various γ-glutamyl compounds.


Subject(s)
Bacillus amyloliquefaciens/enzymology , Bacillus amyloliquefaciens/genetics , gamma-Glutamyltransferase/genetics , gamma-Glutamyltransferase/metabolism , Amino Acid Sequence , Bacillus/enzymology , Bacillus/genetics , Bacillus amyloliquefaciens/metabolism , Cloning, Molecular , Escherichia coli/genetics , Fermentation , Glycylglycine , Molecular Weight , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Republic of Korea , Soy Foods/microbiology , Substrate Specificity , gamma-Glutamyltransferase/chemistry , gamma-Glutamyltransferase/isolation & purification
4.
Mycobiology ; 44(4): 217-236, 2016 Dec.
Article in English | MEDLINE | ID: mdl-28154480

ABSTRACT

Polyporoid and corticioid fungi are among the most important wood-decay fungi. Not only do they contribute to nutrient cycling by decomposing wood debris, but they are also valuable sources for natural products. Polyporoid and corticioid wood-inhabiting fungi were investigated in Odaesan National Park. Fruit bodies were collected and identified based on morphological and molecular analyses using 28S and internal transcribed spacer regions of DNA sequences. As a result, a total of 149 species, 69 genera, 22 families, and 11 orders were recognized. Half (74 species) of the species were polypores, and the other half (75 species) were corticioid fungi. Most of the species belonged to Polyporales (92 species) followed by Hymenochaetales (33 species) and Russulales (11 species). At the genus level, a high number of species was observed from Steccherinum, Hyphodontia, Phanerochaete, Postia, and Trametes. Concerning distribution, almost all the species could be found below 1,000 m, and only 20% of the species were observed from above 1,000 m. Stereum subtomentosum, Trametes versicolor, T. hirsuta, T. pubescens, Bjerkandera adusta, and Ganoderma applanatum had wide distribution areas. Deciduous wood was the preferred substrate for the collected species. Sixty-three species were new to this region, and 21 species were new to Korea, of which 17 species were described and illustrated.

5.
Knee Surg Sports Traumatol Arthrosc ; 23(1): 97-103, 2015 Jan.
Article in English | MEDLINE | ID: mdl-23188498

ABSTRACT

PURPOSE: This study was undertaken to report clinical outcomes after high tibial osteotomy (HTO) in patients with a discoid lateral meniscus and to determine (1) whether discoid lateral meniscus degeneration by magnetic resonance imaging (MRI) progresses after HTO and (2) whether this progression adversely affects clinical results. METHODS: The records of 292 patients (292 knees) who underwent medial opening HTO were retrospectively reviewed, and discoid types and grades of lateral meniscus degeneration as determined by MRI were recorded preoperatively. Of the 292 patients, 17 (5.8%) had a discoid lateral meniscus, and postoperative MR images were obtained at least 2 years after HTO for 15 of these 17 patients. RESULTS: American Knee Society (AKS) pain, knee and function scores significantly improved in the 15 patients after surgery (p < 0.001). Eight (53%) had an incomplete and 7 (47%) had a complete discoid lateral meniscus. By preoperative MRI, the distribution of meniscal degeneration was as follows: grade 1, 4 patients; grade 2, 7 patients; and grade 3, 4 patients. At the final follow-up, the distribution of degeneration was as follows: grade 1, 2 patients; grade 2, 5 patients; and grade 3, 8 patients. Two patients with grade 3 degeneration who did not undergo partial meniscectomy showed tear progression. Thus, 8 of the 15 patients (53%) experienced progressive discoid meniscal degeneration after HTO. Median AKS pain score was significantly lower in the progression group than in the non-progression group (40 vs 45, respectively). CONCLUSION: The results of this study suggest that increased load on the lateral compartment after HTO can accelerate discoid lateral meniscus degeneration by MRI and caution that when a discoid lateral meniscus is found by preoperative MRI, progressive degeneration may occur after HTO and clinical outcome may be adversely affected. LEVEL OF EVIDENCE: Therapeutic study, Level IV.


Subject(s)
Cartilage Diseases/etiology , Knee Joint/surgery , Menisci, Tibial , Osteoarthritis, Knee/surgery , Osteotomy/adverse effects , Tibia/surgery , Cartilage Diseases/pathology , Disease Progression , Female , Humans , Magnetic Resonance Imaging , Male , Menisci, Tibial/pathology , Middle Aged , Pain/surgery , Retrospective Studies , Treatment Outcome
6.
Mycobiology ; 42(2): 140-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25071382

ABSTRACT

In Seoul, a majority of plant communities have undergone significant changes over the last few decades; however, how wood decay fungi have responded and adapted to the changes in vegetation remains unknown. Through an ongoing investigation of Korean indigenous fungi, ca. 300 specimens with poroid basidiocarp were collected in Seoul during 2008~2012. Morphological examination and molecular analysis using the internal transcribed spacer and nuclear large subunit ribosomal DNA region sequences helped identify 38 species belonging to 28 genera, 10 families, and 5 orders in this area. Among them, three polypores, Abundisporus pubertatis, Coriolopsis strumosa, and Perenniporia maackiae were found to be new to South Korea.

7.
J Microbiol Methods ; 97: 56-62, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24374215

ABSTRACT

White rot fungi are essential in forest ecology and are deeply involved in wood decomposition and the biodegradation of various xenobiotics. The fungal ligninolytic enzymes involved in these processes have recently become the focus of much attention for their possible biotechnological applications. Successful bioremediation requires the selection of species with desirable characteristics. In this study, 150 taxonomically and physiologically diverse white rot fungi, including 55 species, were investigated for their performance in a variety of biotechnological procedures, such as dye decolorization, gallic acid reaction, ligninolytic enzymes, and tolerance to four PAHs, phenanthrene, anthracene, fluoranthene, and pyrene. Among these fungi, six isolates showed the highest (>90%) tolerance to both individual PAH and mixed PAHs. And six isolates oxidized gallic acid with dark brown color and they rapidly decolorized RBBR within ten days. These fungi revealed various profiles when evaluated for their biotechnological performance to compare the capability of degradation of PAHs between two groups selected. As the results demonstrated the six best species selected from gallic acid more greatly degraded four PAHs than the other isolates selected via tolerance test. It provided that gallic acid reaction test can be performed to rank the fungi by their ability to degrade the PAHs. Most of all, Peniophora incarnata KUC8836 and Phlebia brevispora KUC9033 significantly degraded the four PAHs and can be considered prime candidates for the degradation of xenobiotic compounds in environmental settings.


Subject(s)
Basidiomycota/isolation & purification , Basidiomycota/metabolism , Biotechnology , Environmental Pollutants/metabolism , Polycyclic Aromatic Hydrocarbons/metabolism , Basidiomycota/drug effects , Basidiomycota/enzymology , Basidiomycota/growth & development , Biodegradation, Environmental , Polycyclic Aromatic Hydrocarbons/pharmacology , Species Specificity
8.
J Gen Appl Microbiol ; 59(4): 279-85, 2013.
Article in English | MEDLINE | ID: mdl-24005177

ABSTRACT

Current studies of the antioxidant activity of fungal resources are mainly focused on the fruiting bodies of edible mushrooms. To access the potential of basidiomycetes in culture-state applications, extracts of solid cultures of 83 basidiomycetous fungi newly isolated from woody materials were prepared at the same concentration (10 mg/ml), and their antioxidant activities were measured using ABTS (2,2'-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid) and DPPH (2,2-diphenyl-1-picrylhydrazyl) radical-scavenging assays. Among the basidiomycetes tested, Cryptoporus volvatus, Daedalea dickinsii, Gloeophyllum abietinum, G. trabeum, Pseudomerulius curtisii and Stereum hirsutum exhibited good antioxidant activities. The EC50 value for the removal of free radicals was lowest (i.e., most effective) in the crude extract of S. sanguinolentum (19.61 g/ml), and reduced DNA damage based on a DNA nicking assay was observed for the extracts from the six basidiomycetous species above.


Subject(s)
Antioxidants/isolation & purification , Basidiomycota/chemistry , Basidiomycota/growth & development , Antioxidants/metabolism , Benzothiazoles/metabolism , Biphenyl Compounds/metabolism , Culture Media/chemistry , Picrates/metabolism , Sulfonic Acids/metabolism
9.
Proc Natl Acad Sci U S A ; 109(26): 10214-7, 2012 Jun 26.
Article in English | MEDLINE | ID: mdl-22689954

ABSTRACT

Fluorescent small molecules have become indispensable tools for biomedical research along with the rapidly developing optical imaging technology. We report here a neural stem cell specific boron-dipyrromethane (BODIPY) derivative compound of designation red 3 (CDr3), developed through a high throughput/content screening of in-house generated diversity oriented fluorescence library in stem cells at different developmental stages. This novel compound specifically detects living neural stem cells of both human and mouse origin. Furthermore, we identified its binding target by proteomic analysis as fatty acid binding protein 7 (FABP7), also known as brain lipid binding protein) which is highly expressed in neural stem cells and localized in the cytoplasm. CDr3 will be a valuable chemical tool in the study and applications of neural stem cells.


Subject(s)
Carrier Proteins/metabolism , Fatty Acid-Binding Proteins/metabolism , Fluorescent Dyes/metabolism , Nerve Tissue Proteins/metabolism , Neural Stem Cells/metabolism , Tumor Suppressor Proteins/metabolism , Animals , Cell Proliferation , Fatty Acid-Binding Protein 7 , Humans , Mice , Neural Stem Cells/cytology , Protein Binding
11.
Chem Commun (Camb) ; 47(15): 4508-10, 2011 Apr 21.
Article in English | MEDLINE | ID: mdl-21387059

ABSTRACT

A bodipy probe was developed for site-specific labeling of tagged proteins inside live cells which displays a large spectral change upon covalent coupling to the designed peptide that contains two pairs of Arg-Cys.


Subject(s)
Acrylates/chemistry , Boron Compounds/chemistry , Molecular Imaging/methods , Molecular Probes/chemistry , Proteins/chemistry , Proteins/metabolism , Amino Acid Sequence , Cell Survival , HEK293 Cells , Humans , Luminescent Proteins/chemistry , Luminescent Proteins/metabolism , Models, Molecular , Protein Structure, Secondary , Red Fluorescent Protein
12.
Mol Biosyst ; 7(4): 1270-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21311795

ABSTRACT

Imaging a specific protein of interest in live cell has versatile applications in biological research. Recently, diverse chemical tags have been developed to overcome the limits of autofluorescence protein (FP) tags. However, current chemical methods still need to be progressed to compete with FPs in the scope of specificity and convenience in staining procedure. We report a novel protein tagging method that provides a convenient and specific fluorescent labeling of membrane proteins. Ω tag is developed by employing a mammalian enzyme glutathione sulfur-transferase omega 1 (GSTO1) and its partner dye, 5-bromomethyl fluorescein (BMF). Ω-tagged membrane proteins were labeled by BMF efficiently for live cell imaging and in-gel analysis. Endocytosis of epidermal growth factor receptor (EGFR) was successfully visualized by using this Ω tagging system. Ω tag will provide a convenient tool for the physiological study of membrane proteins in live cells.


Subject(s)
Fluorescent Dyes/metabolism , Glutathione Transferase/metabolism , Membrane Proteins/metabolism , Staining and Labeling/methods , ErbB Receptors/metabolism , Fluorescent Dyes/chemistry , Gene Expression , Glutathione Transferase/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Intracellular Space/metabolism , Protein Transport , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
13.
Biochem Biophys Res Commun ; 406(3): 389-95, 2011 Mar 18.
Article in English | MEDLINE | ID: mdl-21329655

ABSTRACT

Peroxisome proliferator-activated receptor gamma (PPARγ) agonists, including thiazolidinediones (TZDs), can induce anti-proliferation, differentiation, and apoptosis in various cancer cell types. This study investigated the mechanism of the anticancer effect of TZDs on human ovarian cancer. Six human ovarian cancer cell lines (NIH:OVCAR3, SKOV3, SNU-251, SNU-8, SNU-840, and 2774) were treated with the TZD, which induced dose-dependent inhibition of cell growth. Additionally, these cell lines exhibited various expression levels of PPARγ protein as revealed by Western blotting. Flow cytometry showed that the cell cycle was arrested at the G1 phase, as demonstrated by the appearance of a sub-G1 peak. This observation was corroborated by the finding of increased levels of Bax, p21, PARP, and cleaved caspase 3 in TGZ-treated cells. Interestingly, when we determined the effect of p53-induced growth inhibition in these three human ovarian cancer cells, we found that they either lacked p53 or contained a mutant form of p53. Furthermore, TGZ induced the expression of endogenous or exogenous p63 and p73 proteins and p63- or p73-directed short hairpin (si) RNAs inhibited the ability of TGZ to regulate expression of p21 in these cells. Thus, our results suggest that PPARγ ligands can induce growth suppression of ovarian cancer cells and mediate p63 and p73 expression, leading to enhanced growth inhibition and apoptosis. The tumor suppressive effects of PPARγ ligands may have applications for the treatment of ovarian cancer.


Subject(s)
Apoptosis , DNA-Binding Proteins/metabolism , Nuclear Proteins/metabolism , Ovarian Neoplasms/pathology , PPAR gamma/metabolism , Trans-Activators/metabolism , Tumor Suppressor Proteins/metabolism , Cell Cycle/genetics , Cell Line, Tumor , Cell Proliferation , Female , Gene Expression Regulation, Neoplastic , Humans , Ligands , Ovarian Neoplasms/genetics , Ovarian Neoplasms/metabolism , Transcription Factors , Tumor Protein p73
14.
J Microbiol Biotechnol ; 21(12): 1322-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22210620

ABSTRACT

Filamentous fungi colonizing rice straw were collected from 11 different sites in Korea and were identified based on characterization of their morphology and molecular properties. The fungi were divided into 25 species belonging to 16 genera, including 14 ascomycetes, one zygomycete, and one basidiomycete. Fungal cellulolytic and xylanolytic enzymes were assessed through a two-step process, wherein highly active cellulase- and/or hemicellulaseproducing fungi were selected in a first screening step followed by a second step to isolate the best enzymeproducer. Twenty-five fungal species were first screened for the production of total cellulase (TC), endo-beta-1,4 glucanase (EG), and endo-beta-1,4 xylanase (XYL) using solid-state fermentation with rice straw as substrate. From this screening, six species, namely, Aspergillus niger KUC5183, A. ochraceus KUC5204, A. versicolor KUC5201, Mucor circinelloides KUC6014, Trichoderma harzianum 1 KUC5182, and an unknown basidiomycete species, KUC8721, were selected. These six species were then incubated in liquid Mandels' media containing cellulose, glucose, rice straw, or xylan as the sole carbon source and the activities of six different enzymes were measured. Enzyme production was highly influenced by media conditions and in some cases significantly increased. Through this screening process, Trichoderma harzianum 1 KUC5182 was selected as the best enzyme producer. Rice straw and xylan were good carbon sources for the screening of cellulolytic and xylanolytic enzymes.


Subject(s)
Cellulase/metabolism , Endo-1,4-beta Xylanases/metabolism , Fungal Proteins/metabolism , Fungi/enzymology , Fungi/isolation & purification , Oryza/microbiology , Plant Stems/microbiology , Cellulase/genetics , Endo-1,4-beta Xylanases/genetics , Fermentation , Fungal Proteins/genetics , Fungi/classification , Fungi/genetics , Molecular Sequence Data , Oryza/metabolism , Phylogeny , Plant Stems/metabolism
15.
Biosens Bioelectron ; 26(2): 398-403, 2010 Oct 15.
Article in English | MEDLINE | ID: mdl-20801634

ABSTRACT

Biocompatible surface-enhanced Raman scattering (SERS) nanotag has been developed by chemisorption of novel Raman reporters on gold colloid. We modified our previously published best five reporter molecules (B2, B7, C3, C7 and C9) from triphenylmethine (TM) library using lipoic acid (LA) as a linker to covalently attach the reporters on gold colloid. Among these TM-LA molecules, B2LA showed the highest SERS signal intensity and stability over time. Further, time course SERS intensity of B2LA was compared with currently popular Raman reporter malachite green isothiocyanate (MGITC). The results demonstrated that signal intensity from B2LA was even stable over a period of one month. In vitro SERS screening was performed in cancer cell lines using B2LA containing nanotag conjugated with selective antibodies recognizing HER2 and EGFR cancer proteins. We found reasonably strong SERS signals from both HER2 and EGFR positive cells whereas no signal was measured from respective negative cells. Moreover, we successfully proved this recognition by cell imaging using fluorescein isothiocyanate (FITC) labeled antibody conjugated nanotag. Both SERS and cell-imaging study further confirmed the selective binding of antibody conjugated nanotag to cancer cells over-expressing HER2 and EGFR. In addition, as a proof of concept, in vivo SERS measurement in a mouse model was carried out to detect the nanotag-anchored cancer cells that are subcutaneously injected to the animal.


Subject(s)
Biomarkers, Tumor/analysis , Molecular Probe Techniques , Nanostructures/chemistry , Neoplasms/diagnosis , Neoplasms/metabolism , Receptor, ErbB-2/analysis , Surface Plasmon Resonance/methods , Adsorption , Biocompatible Materials/chemistry , Cell Line, Tumor , Humans , Nanostructures/ultrastructure , Protein Binding
16.
Tumour Biol ; 31(6): 659-66, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20665144

ABSTRACT

Suberoylanilide hydroxamic acid (SAHA) is one of the most widely used histone deacetylase inhibitors. However, the potential advantage of SAHA has not been sufficiently validated as an adjunct to gene therapy of head and neck squamous cell carcinoma (HNSCC). SAHA has been shown to boost the efficiency of gene transfer by upregulating the expression of coxsackie adenoviral receptor on treated cells. The p53 family genes, p63 and p73, have been shown to have characteristics similar to p53, and although they are not confirmed as tumor suppressors, DNA-damaging signals induce their overexpression. We previously reported that the adenovirus-mediated transfer of p63 or p73 showed an effective cancer-killing effect similar to that of p53. In this study, we combined SAHA with adenoviral delivery of p63 or p73 to enhance the efficiency of gene therapy. This combination resulted in a significantly enhanced cancer-killing effect in HNSCC cell lines but had no effect on normal human fibroblasts. SAHA treatment added to ad-p63/p73 gene delivery caused an increase in p21 expression and cleaved poly-ADP ribose polymerase. Our results indicate that adjuvant SAHA treatment could be developed as a therapeutic strategy to enhance the efficiency of adenoviral gene transfer in the treatment of cancer.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/drug therapy , DNA-Binding Proteins/genetics , Genetic Therapy , Head and Neck Neoplasms/drug therapy , Hydroxamic Acids/therapeutic use , Membrane Proteins/genetics , Nuclear Proteins/genetics , Tumor Suppressor Proteins/genetics , Adenoviridae/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Coxsackie and Adenovirus Receptor-Like Membrane Protein , Cyclin-Dependent Kinase Inhibitor p21/metabolism , DNA-Binding Proteins/metabolism , DNA-Binding Proteins/therapeutic use , Drug Therapy, Combination , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , Luciferases/metabolism , Membrane Proteins/metabolism , Membrane Proteins/therapeutic use , Nuclear Proteins/metabolism , Nuclear Proteins/therapeutic use , Poly(ADP-ribose) Polymerases/metabolism , Receptors, Virus/metabolism , Treatment Outcome , Tumor Protein p73 , Tumor Suppressor Proteins/metabolism , Tumor Suppressor Proteins/therapeutic use , Vorinostat
17.
ACS Chem Biol ; 5(5): 449-53, 2010 May 21.
Article in English | MEDLINE | ID: mdl-20205472

ABSTRACT

Recently, the glutathione S-transferase omega 1 (GSTO1) is suspected to be involved in certain cancers and neurodegenerative diseases. However, profound investigation on the pathological roles of GSTO1 has been hampered by the lack of specific methods to determine or modulate its activity in biological systems containing other isoforms with similar catalytic function. Here, we report a fluorescent compound that is able to inhibit and monitor the activity of GSTO1. We screened 43 fluorescent chemicals and found a compound (6) that binds specifically to the active site of GSTO1. We observed that compound 6 inhibits GSTO1 by covalent modification but spares other isoforms in HEK293 cells and demonstrated that compound 6 could report the activity of GSTO1 in NIH/3T3 or HEK293 cells by measuring the fluorescence intensity of the labeled amount of GSTO1 in SDS-PAGE. Compound 6 is a useful tool to study GSTO1, applicable as a specific inhibitor and an activity reporter.


Subject(s)
Enzyme Inhibitors/metabolism , Glutathione Transferase/antagonists & inhibitors , Animals , Catalytic Domain , Cell Line , Chromatography, Gel , Chromatography, Reverse-Phase , Enzyme Activation , Enzyme Inhibitors/analysis , Enzyme Inhibitors/chemistry , Fluorescent Dyes , Glutathione Transferase/analysis , Glutathione Transferase/metabolism , Humans , Immunoprecipitation , Isoenzymes/analysis , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Mice , Models, Molecular , NIH 3T3 Cells , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
18.
J Am Chem Soc ; 132(2): 576-9, 2010 Jan 20.
Article in English | MEDLINE | ID: mdl-20020712

ABSTRACT

During muscle differentiation, mitochondria undergo dramatic changes in their morphology and distribution to prepare for the higher rate of energy consumption. By applying a mitochondria-targeted rosamine library in C2C12 myogenesis, we discovered one compound that controls muscle differentiation. When treated to undifferentiated myoblasts, our selected compound, B25, inhibited myotube formation, and when treated to fully differentiated myotubes, it induced fission of multinucleated myotubes into mononucleated fragments. Compared to myoseverin, which is known for inducing myotube fission by destabilizing microtubules, B25 affects neither microtubule stability nor cell cycle. Further investigation identified that B25 induces myotube fission through the activation of NF-kappaB, which is one of the important signaling pathways linked to skeletal muscle differentiation. So far, the use of small-molecule fluorophores is limited in the discovery of labeling agents or sensors. In addition to their potential as a sensor, here we show the application of fluorescent small molecules in the discovery of a bioactive probe that induces a specific cellular response.


Subject(s)
Cell Differentiation/drug effects , Fluorescent Dyes/metabolism , Fluorescent Dyes/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Muscle Fibers, Skeletal/cytology , Muscle Fibers, Skeletal/drug effects , Animals , Cells, Cultured , Mice , Molecular Weight , Muscle Fibers, Skeletal/metabolism , PC12 Cells , Purines/pharmacology , Rats
19.
Cancer Sci ; 101(2): 482-7, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19922505

ABSTRACT

To overcome the low efficiency of gene therapy, we combined a conditionally replicating adenovirus (CRAd) and an adenoviral vector with a therapeutic gene. CRAd has an oncolytic activity in cancer cells with abnormal Rb activity and helps the replication of therapeutic genes incorporated in the E1-deleted adenovirus. We investigated the anticancer effect of a combination of CRAd and adenovirus carrying tumor necrosis factor-related apoptosis inducing ligand (ad-TRAIL). We expected to see increased gene expression in cancer cells as well as an antitumor effect. With the combined application of CRAd and ad-luciferase in head and neck cancer cell lines, we observed considerably increased luciferase activity that was 10- to 50-fold greater than with ad-luciferase alone. The combination of CRAd and ad-TRAIL showed significant suppression of growth in cell lines and increased the sub-G(1) portion of cells 30-fold compared to any single treatment. The expression of TRAIL was highly amplified by the combined treatment and was accompanied by expression of molecules related to apoptosis. In a xenograft animal model, mice treated with CRAd and ad-TRAIL showed complete regression of established tumors, whereas mice treated with CRAd or ad-TRAIL alone did not. In conclusion, this combined strategy using CRAd and adenovirus carrying a therapeutic gene increased the gene transfer rate and enhanced antitumor effects. We expect that this combination strategy could be extended to a multitarget cancer gene therapy by combining multiple adenoviruses and CRAd.


Subject(s)
Adenoviridae/physiology , Adenovirus E1 Proteins/physiology , Carcinoma, Squamous Cell/therapy , Genetic Therapy , Head and Neck Neoplasms/therapy , Oncolytic Virotherapy , TNF-Related Apoptosis-Inducing Ligand/genetics , Virus Replication , Animals , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Head and Neck Neoplasms/pathology , Humans , Male , Mice , Mice, Inbred BALB C , Xenograft Model Antitumor Assays
20.
J Mov Disord ; 2(2): 88-90, 2009 Oct.
Article in English | MEDLINE | ID: mdl-24868366

ABSTRACT

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system (CNS) caused by JC virus infection in oligodendrocytes, especially in patients with acquired immunodeficiency syndrome (AIDS). Movement disorders associated with PML are very rare. Here, we report a case of PML in an AIDS patient who presented with a cerebellar tremor, caused by lesions in the cerebellar outflow tract. A cerebellar tremor can be a rare clinical manifestation in patients with PML.

SELECTION OF CITATIONS
SEARCH DETAIL